The global pharmaceutical industry experienced an 11% rise in new job postings related to robotics in Q3 2022 compared with the previous quarter, according to GlobalData’s whitepaper on Robotics in Pharmaceutical – Hiring Activity in Q3 2022. This compares to a 2% increase versus Q3 2021.
Notably, Registered Nurses jobs accounted for a 17% share of the global pharmaceutical industry’s robotics-related total new job postings in Q3 2022, up 50% over the prior quarter.
Registered Nurses, with a share of 17%, emerged as the top robotics-related job roles within the pharmaceutical industry in Q3 2022, with new job postings rising by 50% quarter-on-quarter. Health Practitioner Support Technologists and Technicians came in second with a share of 11% in Q3 2022, with new job postings rise by 1% over the previous quarter.
The other prominent robotics roles include Biological Scientists with a 4% share in Q3 2022, Software and Web Developers, Programmers, and Testers with a 3% share of new job postings.
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2022 were Johnson & Johnson, GSK, Staff Care and Novo Nordisk. Together they accounted for a combined share of 35% of all robotics-related active jobs in the pharmaceutical industry.
Johnson & Johnson posted 287 jobs in Q3 2022 and registered a rise of 5% over the previous quarter, followed by GSK with 99 jobs and a 371% growth. Staff Care with 96 jobs and Novo Nordisk with 78 jobs, recorded a 1820% growth and a 8% decrease, respectively, while Takeda Pharmaceutical recorded a 17% decline with 63 job postings during Q3 2022.
The largest share of robotics-related new job postings in the pharmaceutical industry in Q3 2022 was in the US with 77% followed by Australia (3%) and the UK (3%). The share represented by the US was 0.84 percentage points higher than the 76% share it accounted for in Q2 2022.